TotalMarketCap

Entera Bio

ENTXNasdaq IsraelHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$521.767 M

$3.00 -3.54%

Close of 6 Nov 2026

As of 6 Nov 2026, Entera Bio (ENTX) has a market capitalization of $521.8M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$42.0K

#3587 by revenue

Earnings

-$11.4M

Loss-making

Shares outstanding

174,137,771

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #61Iambic TherapeuticsIAM$550.1M
  2. #62Valneva SEVALN$532.9M
  3. #63Entera BioENTX$521.8M
  4. #64SurrozenSRZN$517.4M
  5. #65SL ScienceSLBT$504.7M

What if Entera Bio were worth as much as…

Open the what-if tool →

Gold $28.2T

$162,353.26

Per share 54,118× higher

Bitcoin $1.53T

$8,784.65

Per share 2,928× higher

Apple $5.02T

$28,839.19

Per share 9,613× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Entera Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.